Kras promotes glycolysis intermediates and non-oxidative PPP in pancreatic tumors, and blocking the non-oxidative PPP by the knockdown of RPIA or RPE in the tumor cells inhibits tumor growth [14]. Here, KRAS is linked to neoplasm.